CRAICRA International, Inc.

$177.14-6.6% 1Y

Is the price fair?

Mixed

In its normal P/E range. That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.

1 neutral, 2 without data
Vs its own P/E rangemid-range for this companyderived

In its normal range: P/E 14.5 vs a 18.4 median over 26 quarters (−22% vs median).

Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.